Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Mulder

Showing results (351-360 of 369) with videos related to

Pageof 37
Sort By:
British Journal of Cancer|March 10, 1999
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecinR S de Jong, N H Mulder, D R Uges, et al.
Anticancer Research|November 1, 1995
The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized diseaseH de Graaf, N H Mulder, P H Willemse, et al.
The Netherlands Journal of Medicine|January 1, 1986
High-dosage chemotherapy with autologous bone marrow reinfusion in the treatment of patients with solid tumours. The Groningen experience, 1981-1986N H Mulder, P O Mulder, S Van der Geest, et al.
Annals of Nutrition & Metabolism|January 1, 1994
Effects of supplemental dietary calcium on quantitative and qualitative fecal fat excretion in manJ W Welberg, J F Monkelbaan, E G de Vries, et al.
Anticancer Research|January 1, 1997
Pulmonary function after high-dose chemotherapy with autologous bone marrow transplantation and radiotherapy in patients with advanced loco-regional breast cancerW V Dolsma, E G De Vries, T W Van der Mark, et al.
Cancer Treatment Reports|February 1, 1987
Phase I and pharmacokinetic study of trans-N3P3Az2(NHMe)4N H Mulder, W H Meijers, J D van der Meulen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositisA N Wymenga, W T van der Graaf, L S Hofstra, et al.
British Journal of Cancer|May 18, 2001
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantationC P Schröder, G B Wisman, S de Jong, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodesH de Graaf, P H Willemse, E G de Vries, et al.
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
Modulation of death receptor pathways in oncologyE G E de Vries, T Timmer, N H Mulder, et al.
Pageof 37

Showing results (351-360 of 369) with videos related to

Sort By:
Pageof 37
British Journal of Cancer|March 10, 1999
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecinR S de Jong, N H Mulder, D R Uges, et al.
Anticancer Research|November 1, 1995
The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized diseaseH de Graaf, N H Mulder, P H Willemse, et al.
The Netherlands Journal of Medicine|January 1, 1986
High-dosage chemotherapy with autologous bone marrow reinfusion in the treatment of patients with solid tumours. The Groningen experience, 1981-1986N H Mulder, P O Mulder, S Van der Geest, et al.
Annals of Nutrition & Metabolism|January 1, 1994
Effects of supplemental dietary calcium on quantitative and qualitative fecal fat excretion in manJ W Welberg, J F Monkelbaan, E G de Vries, et al.
Anticancer Research|January 1, 1997
Pulmonary function after high-dose chemotherapy with autologous bone marrow transplantation and radiotherapy in patients with advanced loco-regional breast cancerW V Dolsma, E G De Vries, T W Van der Mark, et al.
Cancer Treatment Reports|February 1, 1987
Phase I and pharmacokinetic study of trans-N3P3Az2(NHMe)4N H Mulder, W H Meijers, J D van der Meulen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositisA N Wymenga, W T van der Graaf, L S Hofstra, et al.
British Journal of Cancer|May 18, 2001
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantationC P Schröder, G B Wisman, S de Jong, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodesH de Graaf, P H Willemse, E G de Vries, et al.
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
Modulation of death receptor pathways in oncologyE G E de Vries, T Timmer, N H Mulder, et al.
Pageof 37